GM vs PBYI · P/E 7.5, rev $91.65B vs P/E 4.3, rev $56.5M
General Motors Company (GM) versus Puma Biotechnology Inc (PBYI) — a side-by-side from cached financials, not a winner call.
General Motors Company (GM) is a auto manufacturers company listed on US. It is led by Mary T. Barra.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Latest reported GM revenue for 2026-06-30 was $91.65B. Net income was $3.93B. GM currently screens at market cap $51.33B and trailing P/E 7.5.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
GM currently screens at market cap $51.33B and trailing P/E 7.5. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Not investment advice. Open the GM and PBYI stock pages for the full models.
Not investment advice.